BrightEdge - American Cancer Society logo

BrightEdge - American Cancer Society

Description

BrightEdge - American Cancer Society focuses on investing in cancer-focussed therapies and technologies.

Investor Profile

BrightEdge - American Cancer Society has made 4 investments, with 4 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (75%)
  • Pre Seed (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Health Diagnostics
  • Therapeutics
  • Health Care
  • Medical
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BrightEdge - American Cancer Society frequently co-invest with?

EV
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
CI
North America, California, United States, Berkeley
Co-Investments: 1
Caffeinated Capital
North America, California, United States, San Francisco
Co-Investments: 1
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Freeflow Ventures
North America, California, United States, Pasadena
Co-Investments: 1
Pioneer Fund
North America, California, United States, San Francisco
Co-Investments: 1
Illumina Ventures
North America, California, United States, Foster City
Co-Investments: 1
Lexi Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
LongeVC
Europe, Ticino, Switzerland, Lugano
Co-Investments: 1
TP
Europe, England, United Kingdom, London
Co-Investments: 1

Which angels does BrightEdge - American Cancer Society often collaborate with?

MP
North America, Illinois, United States, Chicago
Shared Deals: 1

What are some of recent deals done by BrightEdge - American Cancer Society?

Cerula Care

Raleigh, North Carolina, United States

Cerula Care specializes in behavioral health services for people with chronic conditions.

Health CareMedicalWellness
SeedFeb 12, 2025
Amount Raised: $3,700,000
TippingPoint Biosciences

San Francisco, California, United States

TippingPoint Biosciences is developing therapeutics that target genome packaging states in diseases like cancer.

Biotechnology
Pre SeedSep 4, 2024
Predicta Biosciences

Boston, Massachusetts, United States

Predicta Biosciences uses multiomics and liquid biopsies in precision oncology to create innovative diagnostics and therapies.

BiotechnologyHealth DiagnosticsTherapeutics
SeedJul 16, 2024
Amount Raised: $5,200,000
Catena Biosciences

Berkeley, California, United States

Catena Biosciences is a biotechnology company that offers protein conjugation, building biologic structures, and medical research.

BiotechnologyLife Science
SeedMay 10, 2024
Amount Raised: $2,350,000